Following recent news regarding a shortage of pathologists in Australia and worldwide, Optiscan has been featured in a special report by Stockhead today on how our technology can address this situation.

Our pioneering slide-free, biopsy-free technology has been miniaturised and perfected to enable clinicians and pathologists to diagnose cancerous and precancerous in real-time, removing the need for time consuming tissue biopsies, sample collection, specimen processing, and traditional use of glass slides.

Read the report here